Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03435198 · ClinicalTrials.gov registry record
Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes
A clinical trial, sponsored by East Tennessee State University.
- Completed
- Registry status
- 10
- Enrollment target
NCT03435198: Completed study, sponsored by East Tennessee State University.
NCT03435198 is a clinical trial that has completed, run by East Tennessee State University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03435198 has completed, sponsored by East Tennessee State University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The investigators are investigating the "biochemical fingerprint" of hypoglycemia (low blood sugar) in the breath of people with type 1 diabetes.
Primary Outcome
Detectable difference in volatile organic compounds (anticipate up to 120-150 different ion signals to be assessed) in human breath during low blood sugar (\<70 mg/dL) compared to normal blood sugar (70-180). As this is a 'hypothesis generating' pilot study, the investigators are observing what compounds are present and in what concentrations -- this is the reason for nonspecific outcome measures
Interventions
- DIAGNOSTIC_TEST Collect exhaled breath during low and normal blood sugar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2018-08-30 |
What the finished NCT03435198 record still lists
NCT03435198 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Collect exhaled breath during low and normal blood sugar is the first listed.
NCT03435198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03435198 about?
NCT03435198 is a clinical study titled "Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes". The investigators are investigating the "biochemical fingerprint" of hypoglycemia (low blood sugar) in the breath of people with type 1 diabetes.
What is the current status of trial NCT03435198?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2018-03-01. Estimated completion is 2018-08-30.
What interventions are being tested in trial NCT03435198?
The interventions under investigation include: Collect exhaled breath during low and normal blood sugar (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03435198?
This trial is sponsored by East Tennessee State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI